US Stock MarketDetailed Quotes
CTSO Cytosorbents
- 0.753
- -0.079-9.51%
Close Jun 18 16:00 ET
- 0.753
- 0.0000.00%
Post 16:30 ET
40.89MMarket Cap-1276P/E (TTM)
0.860High0.750Low243.64KVolume0.860Open0.832Pre Close193.66KTurnover0.53%Turnover RatioLossP/E (Static)54.31MShares4.29052wk High2.16P/B34.55MFloat Cap0.75052wk Low--Dividend TTM45.88MShs Float98.750Historical High--Div YieldTTM13.22%Amplitude0.750Historical Low0.794Avg Price1Lot Size
About Cytosorbents Company
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Company Profile
SymbolCTSO
Company NameCytosorbents
Listing DateDec 23, 2014
Founded1997
CEODr. Phillip P. Chan, M.D.,PhD
MarketNASDAQ
Employees186
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address305 College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-732-329-8885
Websitehttp://cytosorbents.com
Company Executives
- Name
- Position
- Salary
- Dr. Phillip P. Chan, M.D.,PhD
- Chief Executive Officer and Director
- 1.33M
- Dr. Efthymios Nikolaos Deliargyris, M.D.
- Chief Medical Officer
- 1.06M
- Kathleen P. Bloch, C.P.A.,M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- 816.08K
- Vincent J. Capponi, M.S.
- President and Chief Operating Officer
- 1.11M
- Michael G. Bator
- Chairman of the Board
- 161.70K
- Jiny Kim, M.B.A.
- Independent Director
- 101.80K
- Alan D. Sobel, C.P.A.
- Independent Director
- 118.47K
- Dr. Edward R. Jones, M.B.A.,M.D.
- Independent Director
- 101.93K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg